- Home
- RYM vs RNXT Comparison
RYM vs RNXT Comparison
Compare RYM & RNXT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | RYM | RNXT |
|---|---|---|
| Founded | 2016 | 2012 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Farming/Seeds/Milling | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Staples | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.1M | 37.4M |
| IPO Year | 2021 | 2021 |
Fundamental Metrics
Financial Performance| Metric | RYM | RNXT |
|---|---|---|
| Price | $16.24 | $0.90 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $7.75 |
| AVG Volume (30 Days) | 23.3K | ★ 191.9K |
| Earning Date | 03-20-2026 | 03-30-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $16,303,000.00 | $928,000.00 |
| Revenue This Year | N/A | $2,795.35 |
| Revenue Next Year | N/A | $272.69 |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1338.92 | N/A |
| 52 Week Low | $13.22 | $0.70 |
| 52 Week High | $53.65 | $1.45 |
Technical Indicators
Market Signals| Indicator | RYM | RNXT |
|---|---|---|
| Relative Strength Index (RSI) | 41.56 | 45.36 |
| Support Level | $14.73 | $0.92 |
| Resistance Level | $18.75 | $1.08 |
| Average True Range (ATR) | 1.92 | 0.07 |
| MACD | 0.16 | -0.01 |
| Stochastic Oscillator | 31.73 | 30.14 |
Price Performance
Historical ComparisonAbout RYM RYTHM Inc.
Rythm Inc is a USA Based company. The Company's portfolio of brands delivers well-being to millions of Americans every year. The company features some of the recognized and trusted names in the cannabis and hemp industries, including RYTHM, incredibles, Dogwalkers, Beboe, Senorita THC Margaritas, &Shine, Doctor Solomon's and Good Green in thousands of physical locations and online channels. With products rooted in quality, safety, and innovation, the Company is shaping cannabis experiences that enhance daily life.
About RNXT RenovoRx Inc.
RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.